|
|
||||||||



Divisions of
* Immunology and Rheumatology and
Bone Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305; and
Core Research for Engineering, Science, and Technology and Department of Molecular Immunology, Chiba University Graduate School of Medicine, Chiba, Japan
Immune tolerance to organ transplants has been reported in
laboratory animals and in humans after nonmyeloablative conditioning of
the host and infusion of donor bone marrow cells. We examined the
mechanisms of immune tolerance to mouse cardiac allografts in
MHC-mismatched hosts that developed mixed chimerism after
posttransplant conditioning with a 2-wk course of multiple doses of
lymphoid tissue irradiation, depletive anti-T cell Abs, and an
infusion of donor bone marrow cells. When CD1-/- or
J
281-/- hosts with markedly reduced NK T
cells were used instead of wild-type hosts, then the conditioning
regimen failed to induce tolerance to the heart allografts despite the
development of mixed chimerism. Tolerance could be restored to the
CD1-/- hosts by infusing enriched T cells from the bone
marrow of wild-type mice containing CD1-reactive T cells but not from
CD1-/- host-type mice. Tolerance could not be induced in
either IL-4-/- or IL-10-/- hosts given the
regimen despite the development of chimerism and clonal deletion of
host T cells to donor MHC-Ags in the IL-10-/- hosts. We
conclude that immune tolerance to bone marrow transplants involves
clonal deletion, and tolerance to heart allografts in this model also
involves regulatory CD1-reactive NK T cells.
This article has been cited by other articles:
![]() |
J. Mariotti, J. Foley, K. Ryan, N. Buxhoeveden, V. Kapoor, S. Amarnath, and D. H. Fowler Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway Blood, December 1, 2008; 112(12): 4765 - 4775. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Weissman and J. A. Shizuru The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases Blood, November 1, 2008; 112(9): 3543 - 3553. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Scandling, S. Busque, S. Dejbakhsh-Jones, C. Benike, M. T. Millan, J. A. Shizuru, R. T. Hoppe, R. Lowsky, E. G. Engleman, and S. Strober Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation N. Engl. J. Med., January 24, 2008; 358(4): 362 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Schimmelpfennig, S. Schulz, C. Arber, J. Baker, I. Tarner, J. McBride, C. H. Contag, and R. S. Negrin Ex Vivo Expanded Dendritic Cells Home to T-Cell Zones of Lymphoid Organs and Survive in Vivo after Allogeneic Bone Marrow Transplantation Am. J. Pathol., November 1, 2005; 167(5): 1321 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Pellicci, K. J. L. Hammond, J. Coquet, K. Kyparissoudis, A. G. Brooks, K. Kedzierska, R. Keating, S. Turner, S. Berzins, M. J. Smyth, et al. DX5/CD49b-Positive T Cells Are Not Synonymous with CD1d-Dependent NKT Cells J. Immunol., October 1, 2005; 175(7): 4416 - 4425. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Haraguchi, T. Takahashi, A. Matsumoto, T. Asai, Y. Kanda, M. Kurokawa, S. Ogawa, H. Oda, M. Taniguchi, H. Hirai, et al. Host-Residual Invariant NK T Cells Attenuate Graft-versus-Host Immunity J. Immunol., July 15, 2005; 175(2): 1320 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-W. Kim, Y.-J. Chung, T.-G. Kim, Y.-L. Kim, and I.-H. Oh Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation Blood, March 1, 2004; 103(5): 1941 - 1948. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |